There were 1,257 press releases posted in the last 24 hours and 429,724 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image